Keyphrases
Antitumor Activity
14%
ATP Binding Site
14%
Breast Cancer Cells
28%
C-ring
14%
C-terminal Inhibitors
100%
Client Proteins
28%
Cytotoxicity
14%
Deguelin
100%
Heat Shock Protein 90 (Hsp90)
100%
Heat Shock Response
14%
Homology Modeling
14%
Human Epidermal Growth Factor Receptor 2-positive Breast Cancer
100%
Inhibitor Screening
14%
Mechanistic Studies
14%
Molecular Docking Studies
14%
Novel Antitumor Agents
14%
Resistant Breast Cancer
14%
Synthesized Compounds
14%
Trastuzumab
14%
Trastuzumab-resistant
14%
Biochemistry, Genetics and Molecular Biology
Adenosine Triphosphate
14%
Antineoplastic Activity
14%
Binding Site
14%
C-Terminus
100%
Cancer Cell
28%
Cytotoxicity
14%
Deguelin
100%
Docking (Molecular)
14%
Downregulation
14%
Epidermal Growth Factor Receptor
100%
Heat Shock Protein
100%
Heat Shock Response
14%
Trastuzumab
28%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
14%
Anticarcinogen
14%
Antitumor Activity
14%
Binding Site
14%
Breast Cancer
28%
Cytotoxicity
14%
Deguelin
100%
Heat Shock Protein 90
100%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
100%
Trastuzumab
28%